Here's How Much You'd Need to Invest in HDV to Generate $500 per Month in Dividends

The iShares Core High Dividend ETF (HDV) targets high-yield stocks from a universe that meets multiple Morningstar quality measures. It currently pays a dividend that yields 3.0%.

The Motley Fool • Jun 23, 2026

SCHD vs. HDV: Which Dividend ETF Is the Better Buy for Long-Term Investors?

The Schwab U.S. Dividend Equity ETF (SCHD) offers a lower expense ratio and a higher dividend yield than the iShares Core High Dividend ETF (HDV). HDV has delivered higher 5-year total returns and maintains a lower beta of 0.52, indicating less price sensitivity to broader market moves.

The Motley Fool • Jun 20, 2026

Want Decades of Passive Income? Here Are 2 ETFs Worth Owning Forever.

The Schwab U.S. Dividend Equity ETF considers balance sheet quality, dividend history, and yield to produce its portfolio. The iShares Core High Dividend ETF emphasizes balance sheet health and the highest yields within a group of qualifying stocks.

The Motley Fool • Jun 19, 2026

Is This Dividend ETF a Millionaire Maker?

Investing in dividend stocks remains a great long-term strategy for building a retirement portfolio. The iShares Core High Dividend ETF (HDV) uses a smart portfolio-construction approach to identify financially healthy stocks with above-average yields.

The Motley Fool • Jun 18, 2026

Is iShares Core High Dividend ETF (HDV) a Strong ETF Right Now?

Making its debut on 03/29/2011, smart beta exchange traded fund iShares Core High Dividend ETF (HDV) provides investors broad exposure to the Style Box - Large Cap Value category of the market.

Zacks Investment Research • Jun 10, 2026

Retirees: Here's Why HDV Makes More Sense Than JEPI for Your Income Portfolio

The JPMorgan Equity Premium Income ETF (JEPI) built its reputation on a strong year in 2022. Since then, it's trailed the S&P 500 badly, and its distribution yield has fallen significantly.

The Motley Fool • Jun 10, 2026

HDV vs. FDVV: One of These High-Dividend ETFs Has a Surprising Secret

iShares Core High Dividend ETF offers a more competitive expense ratio than Fidelity High Dividend ETF but has generated a lower total return over the past 12 months. Fidelity High Dividend ETF provides exposure to growth sectors like technology and financials while iShares Core High Dividend ETF prioritizes energy and healthcare.

The Motley Fool • Jun 3, 2026

HDV: This May Not Be The ETF You Want, But It Could Be The One You Need Right Now

The iShares Core High Dividend ETF offers defensive exposure with a 2.90% yield, focusing on quality, high-dividend companies with strong moats. HDV's portfolio is concentrated in consumer staples, energy, and healthcare, with minimal tech exposure, making it less likely to outperform in tech-driven rallies. Given rising inflation and geopolitical uncertainty, HDV is positioned to preserve capital and provide income stability, appealing to defensive and income-focused investors.

Seeking Alpha • May 23, 2026

How Do the Vanguard and iShares High Dividend ETFs Stack Up on Fees, Yield, and Performance?

Vanguard High Dividend Yield ETF offers a lower expense ratio but has a lower trailing-12-month dividend yield than iShares Core High Dividend ETF. iShares Core High Dividend ETF maintains a more concentrated portfolio of 74 holdings, while Vanguard High Dividend Yield ETF holds more than 600 securities.

The Motley Fool • May 22, 2026

FDA Grants Accelerated Approval to Gilead's Hepcludex® (bulevirtide-gmod), the First and Only Approved Treatment for Chronic Hepatitis Delta Virus (HDV)

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Hepcludex® (bulevirtide-gmod) 8.5 mg for the treatment of adults living with chronic hepatitis delta virus (HDV) infection, making it the first and only approved treatment for HDV in the United States. The FDA granted accelerated approval to Hepcludex based on reductions in HDV RNA and normalization of alanine aminotrans.

Business Wire • May 22, 2026